Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES
Pharmas Market Video Gallery
A bright spot in the beaten down pharma sector, with CNBC's Mike Huckman
An update on the sector, with CNBC's Mike Huckman
PHARMA WATCH LIST
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
See all Pharmas Market PostsPharma's Market with Mike Huckman
Font size:

CNBC.com

According to The Center for Responsive Politics' web site Pfizer [PFE  Loading...      ()   ] Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here.

Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate. His name doesn't come up on the donor list for Sen. Barack Obama, Sen. John McCain or Gov. Mike Huckabee. As I've pointed out before, Kindler's support stands in stark contrast to his predecessor Hank McKinnell who was a big backer of President Bush. And here's the leader of the world's biggest drug company giving money to one of the candidates who frequently on the stump says she will "take on" the pharmaceutical companies. No judgements, just pointing out a fact.

I did a quick search of the names of the CEOs of the other major American drugmakers--Bristol-Myers Squibb, Wyeth, Eli Lilly, Schering-Plough, Merck and J & J--and couldn't find any other individual contributions to Obama, McCain, Clinton or Huckabee.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

The CRP is in the process of sorting out the latest campaign finances that were submitted on Feb. 20th. I'm waiting on the CRP to post the updated pharmaceutical industry donation figures. They should go live sometime this week and when they do I'll check who's on top.

P.S. The FDA Advisory Committee meeting on experimental antibiotic drugs to treat MRSA from Theravance and JNJ that was scheduled to start tomorrow has been canceled. The Associated Press says the agency wants more time to review outstanding issues regarding the Theravance drug.

Questions?  Comments? 

© 2008 CNBC, Inc. All Rights Reserved

Permalink: /id/23337341

HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis